HOUSTON, March 3, 2015 /PRNewswire/ -- Cyberonics,
Inc. (NASDAQ: CYBX), a global leader in medical devices for the
treatment and management of epilepsy, today announced it will
participate in the Barclays Global Healthcare Conference on
Wednesday, March 11, 2015, in
Miami.
Dan Moore, Cyberonics' President
and Chief Executive Officer, will speak at 1:05 PM Eastern Time. The session will be
conducted in a fireside chat format, and no formal materials will
be presented. A live audio webcast of the presentation can be
accessed by clicking on the Investor Relations link on the
Cyberonics home page at www.cyberonics.com on March 11, 2015.
About Cyberonics, Inc. and the VNS Therapy®
System
Cyberonics, Inc. is a medical device company with core expertise
in neuromodulation. The company developed and markets the VNS
Therapy System, which is FDA-approved for the treatment of
refractory epilepsy and treatment-resistant depression. The
VNS Therapy System uses an implanted medical device that delivers
pulsed electrical signals to the vagus nerve. Cyberonics
markets the VNS Therapy System in selected markets worldwide.
Additional information on Cyberonics and the VNS Therapy System
is available at www.cyberonics.com.
Contact Information
Greg Browne, CFO
Cyberonics, Inc.
100 Cyberonics Blvd.
Houston, TX 77058
Main: (281) 228-7262
Fax: (281) 218-9332
ir@cyberonics.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cyberonics-to-present-at-the-barclays-global-healthcare-conference-300044019.html
SOURCE Cyberonics, Inc.